TOPLINE: Low-dose doxycycline showed comparable efficacy with high-dose treatment in patients with lymphocytic scarring alopecia, with a lower rate of adverse events (AEs) and related discontinuations. METHODOLOGY: Researchers conducted a retrospective review of 241 patients (82.6% women; mean age, 58.4 years; 49.8% White; 14.1% Black) diagnosed with lymphocytic scarring alopecia between 2009 and 2023 to ...
TheFeel, námestí Smirických, Kostelec n. C. Lesy 28163, Czechia
+31613054419
info@thefeel.org
Copyright © 2023 news.thefeel.org. All Rights Reserved
